Aloxi

Aloxi 250 micrograms solution for injection

Aloxi is indicated for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, in adults and paediatric patients 1 month of age and older.

The active ingredient contained in this product is Palonosetron (as Hydrochloride).

Aloxi is currently available in the following presentation:

• 250mg/5ml solution for injection available in packs of 1 vial

This product is distributed in the Republic of Ireland by Fannin Ltd in partnership with Sinclair IS Pharma (This link will take you to a non-Fannin Ltd. website.  Fannin Ltd. does not recommend, endorse or accept liability for sites controlled by third-parties).

For a copy of the SPC please click here.

Method of Sale: POM

EU Number: EU 1/04/306/001

MAH Holder: Helsinn Birex Pharmaceuticals Ltd. Damastown Mulhuddart Dublin 15 Ireland

For any further information please speak to your local Fannin Representative or contact our medical information department for a copy of the SPC at medical@dccvital.com or via phone on 01-2907000.

Additional information available on request.

Date of preparation: July 2018

IE2018/091/00